SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Proteonomix, Inc. – ‘10-12G’ on 8/4/09 – EX-10.12

On:  Tuesday, 8/4/09, at 9:58am ET   ·   Accession #:  1091818-9-219   ·   File #:  0-53750

Previous ‘10-12G’:  None   ·   Next:  ‘10-12G/A’ on 10/20/09   ·   Latest:  ‘10-12G/A’ on 4/14/10   ·   8 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 8/04/09  Proteonomix, Inc.                 10-12G                31:1.5M                                   Yes International/FA

Registration of Securities (General Form)   —   Form 10
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-12G      Registration Statement                              HTML    532K 
 2: EX-2.1      Plan of Acquisition                                 HTML    173K 
 3: EX-3.1      Articles of Incorporation                           HTML     13K 
12: EX-3.10     By-Laws                                             HTML     59K 
 4: EX-3.2      Articles of Incorporation                           HTML     12K 
 5: EX-3.3      Articles of Incorporation                           HTML     14K 
 6: EX-3.4      Articles of Incorporation                           HTML     12K 
 7: EX-3.5      Articles of Incorporation                           HTML     12K 
 8: EX-3.6      Articles of Incorporation                           HTML     12K 
 9: EX-3.7      Articles of Incorporation                           HTML     14K 
10: EX-3.8      Articles of Incorporation                           HTML     13K 
11: EX-3.9      Articles of Incorporation                           HTML     53K 
13: EX-10.1     Material Contract                                   HTML     44K 
22: EX-10.10    Material Contract                                   HTML     33K 
23: EX-10.11    Material Contract                                   HTML     48K 
24: EX-10.12    Material Contract                                   HTML     16K 
25: EX-10.13    Material Contract                                   HTML     21K 
26: EX-10.14    Material Contract                                   HTML     43K 
27: EX-10.15    Material Contract                                   HTML     27K 
28: EX-10.16    Material Contract                                   HTML     18K 
29: EX-10.17    Material Contract                                   HTML     47K 
30: EX-10.18    Material Contract                                   HTML     42K 
31: EX-10.19    Material Contract                                   HTML     30K 
14: EX-10.2     Material Contract                                   HTML     26K 
15: EX-10.3     Material Contract                                   HTML     27K 
16: EX-10.4     Material Contract                                   HTML     45K 
17: EX-10.5     Material Contract                                   HTML     29K 
18: EX-10.6     Material Contract                                   HTML     34K 
19: EX-10.7     Material Contract                                   HTML     14K 
20: EX-10.8     Material Contract                                   HTML     43K 
21: EX-10.9     Material Contract                                   HTML     28K 


EX-10.12   —   Material Contract


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



Exhibit 10.12

 

AMENDMENT TO EMPLOYMENT AGREEMENT

BY AND BETWEEN PROTEONOMIX, INC. AND MICHAEL COHEN


This amended agreement (the “Agreement”) is made as of this 1ST day of July, 2009, to an employment agreement originally executed on January 5, 2005, as restated January 4, 2008, (the “Employment Agreement”) by and between National Stem Cell Holding, Inc., (renamed Proteonomix, Inc.) a Delaware corporation (“PROT)  with an address a 187 Mill Lane, Mountainside, New Jersey 07092 and Michael Cohen, with an address at7 Stanford Court, West Orange, New Jersey 07052 (the Employee”) (the parties hereto are herein referred to as the “Parties”).

NOW, THEREFORE, in consideration of the mutual covenants herein set forth and as set forth in the Employment Agreement, the Employment Agreement is hereby amended as follows:

1.

The Employee and his brother, Jacob Cohen, co-owned all rights, title and interest in and to certain technologies embodied in patent applications therefor  (the “Technologies”) with the U.S. Patent and Trademark Office filed on December 19, 2006, as follows: Patent Application Serial No. 60/875,558 (Umbilical Cord Stem Cell Secreted Product Derived Topical Compositions and Methods of Use Thereof), and Patent Application Serial No. 60/875,553 (Embryonic Germ Cell Secreted Product Derived Topical Compositions and Methods of Use Thereof) (herein, the “Properties”); and assigned the Techynologies to PROT for consideration of (a) 50,000 Shares of PROT’s Series C Preferred Stock, par value $.001 per share and (b) the right (the “Right”)  to receive 20% of the common stock of PROT’s subsidiary, Proteoderm, Inc. in the event Proteoderm, Inc. shall become a public company. The Right shall be non-transferable except to the JSM Family Trust

2.

Commencing on the date hereof, for any patent application or grant in which the Employee is named as investigator or inventor which is assigned to PROT or to NSC, or any successor, the Employee shall receive 50,000 Shares of PROT’s Common Stock.

3.

The Employee’s monthly car rental reimbursement allowance is increased from $750 to $1,000.

4.

To the extent that any clause herein is contradicted by a clause in the Employment Agreement, the clause herein shall supersede the clause in the Employment Agreement.

5.

The term of the Agreement shall be for a period of five years from the date hereof, and will automatically renew for an additional five-year period unless terminated in writing in accordance with the Employment Agreement.

6.

That portion of the Employment Agreement allowing for the continuation of the Employee’s benefit (the “{Benefits”), including but not limited to options if any, for a period of thirty-six months after termination, is amended to reflect that the Benefits are applicable upon the death of the Employee, and that the payment of the continued compensation pursuant to the Agreement shall be made to the JSM Family Trust

7.

Clauses in the Employment Agreement not affected by the Agreement shall remain in full force and effect.



1



SIGNATURE PAGE

IN WITNESS WHEREOF, the Parties have executed this Amendment as of the date first above written.


PROTEONOMIX, INC.


/s/ Joel Pensley

/s/ Michael Cohen

Joel Pensley, Secretary

Michael Cohen



2




Dates Referenced Herein

This ‘10-12G’ Filing    Date    Other Filings
Filed on:8/4/09None on these Dates
1/4/08
12/19/06
1/5/05
 List all Filings 


8 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/21/10  SEC                               UPLOAD10/06/17    1:20K  Proteonomix, Inc.
 4/12/10  SEC                               UPLOAD10/06/17    1:43K  Proteonomix, Inc.
 3/04/10  SEC                               UPLOAD10/06/17    1:47K  Proteonomix, Inc.
 2/22/10  SEC                               UPLOAD10/06/17    1:44K  Proteonomix, Inc.
 1/25/10  SEC                               UPLOAD10/06/17    1:52K  Proteonomix, Inc.
12/22/09  SEC                               UPLOAD10/06/17    1:80K  Proteonomix, Inc.
11/06/09  SEC                               UPLOAD10/06/17    1:88K  Proteonomix, Inc.
 8/31/09  SEC                               UPLOAD10/06/17    1:231K Proteonomix, Inc.
Top
Filing Submission 0001091818-09-000219   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Apr. 18, 5:33:50.2pm ET